Results 71 to 80 of about 254,297 (340)
Use of medication by young people with attention-deficit/hyperactivity disorder [PDF]
The document attached has been archived with permission from the editor of the Medical Journal of Australia (26 April 2007). An external link to the publisher’s copy is includedObjectivesTo examine the prevalence of psychotropic medication use by ...
Baghurst, P.+4 more
core +1 more source
ABSTRACT Angelman syndrome (AS) is a neurodevelopmental disorder characterized by severe developmental delays, typical facial features, ataxia, seizures, speech impairments, sleeping difficulties, and a happy demeanor. Caregivers of individuals with AS often report feeding problems, with difficulties including issues with obesity, failure to gain ...
Ciara Cassidy+6 more
wiley +1 more source
Background and aims: New therapeutic options such as lisdexamfetamine and guanfacine have recently become available for the treatment of attention deficit hyperactivity disorder.
Brett, J +7 more
core +1 more source
ABSTRACT Natural History Studies can help inform clinician and caregiver expectations, form the basis of management guidelines, and provide a comparator for therapeutic intervention. In rare conditions, where collection of prospective longitudinal data is untimely and impractical, quasi‐natural history data—from multiple individuals of different ages ...
E. Woods+16 more
wiley +1 more source
Attention-deficit hyperactivity disorder
Attention-deficit hyperactivity disorder (ADHD), like other psychiatric disorders, represents an evolving construct that has been refined and developed over the past several decades in response to research into its clinical nature and structure. The clinical presentation and course of the disorder have been extensively characterised.
Jonathan, Posner+2 more
openaire +3 more sources
Speech and Language Disorders Associated With 7q31 Deletions Implicating FOXP2
ABSTRACT Some 7q31 deletions encompass FOXP2, a gene long associated with speech and language disorders. Intragenic pathogenic FOXP2 variants cause FOXP2‐related speech and language disorder, which has been well characterized in the literature. Conversely, the phenotype associated with 7q31 deletions is neglected.
Lottie D. Morison+3 more
wiley +1 more source
Which executive functioning deficits are associated with AD/HD, ODD/CD and comorbid AD/HD+ODD/CD? [PDF]
Item does not contain fulltextThis study investigated (1) whether attention deficit/hyperactivity disorder (AD/HD) is associated with executive functioning (EF) deficits while controlling for oppositional defiant disorder/conduct disorder (ODD/CD), (2 ...
A. Angold+109 more
core +1 more source
CLCN4‐Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities
ABSTRACT Speech and language difficulties are a core feature of the CLCN4‐related neurodevelopmental condition, but these have not been well described. Here we systematically phenotype speech and language in 13 participants (10 female, aged 1 year 10 months–41 years 10 months) with pathogenic CLCN4 variants (12 missense de novo, 1 premature stop codon ...
Alexandra Garrett+4 more
wiley +1 more source
Effects of relaxation training combined with basic psychological intervention on attention deficit factor scores in children with attention deficit hyperactivity disorder [PDF]
Objective To evaluate the effect of relaxation training combined with basic psychological intervention on attention deficit factor score in children with attention deficit hyperactivity disorder.
XU Hongning, LU Linyang, CHEN Xiaoyun, KAI Hongxia, WANG Yi, ZHU Qidong, HUANG Yuanyuan
doaj +1 more source
The history of attention deficit hyperactivity disorder [PDF]
The contemporary concept of attention deficit hyperactivity disorder (ADHD) as defined in the DSM-IV-TR (American Psychiatric Association 2000) is relatively new. Excessive hyperactive, inattentive, and impulsive children have been described in the literature since the nineteenth century.
Oliver Tucha+4 more
openaire +4 more sources